Zentek Ltd. (ZTEK)
NASDAQ: ZTEK · Real-Time Price · USD
0.649
-0.004 (-0.54%)
At close: Mar 9, 2026, 4:00 PM EDT
0.612
-0.037 (-5.67%)
After-hours: Mar 9, 2026, 6:16 PM EDT
Zentek Revenue
Zentek had revenue of 65.28K CAD in the quarter ending December 31, 2025, with 73.07% growth. This brings the company's revenue in the last twelve months to 942.88K, up 1,358.30% year-over-year. In the fiscal year ending March 31, 2025, Zentek had annual revenue of 872.50K with 2,826.26% growth.
Revenue (ttm)
942.88K CAD
Revenue Growth
+1,358.30%
P/S Ratio
99.91
Revenue / Employee
52,382 CAD
Employees
18
Market Cap
68.70M USD
Revenue Chart
* This company reports financials in CAD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 872.50K | 842.68K | 2,826.26% |
| Mar 31, 2024 | 29.82K | -43.04K | -59.07% |
| Mar 31, 2023 | 72.86K | -274.33K | -79.02% |
| Mar 31, 2022 | 347.18K | 344.83K | 14,642.38% |
| Mar 31, 2021 | 2.36K | - | - |
| Mar 31, 2020 | Pro | Pro | Pro |
| Mar 31, 2019 | Pro | Pro | Pro |
| Mar 31, 2018 | Pro | Pro | Pro |
| Mar 31, 2017 | Pro | Pro | Pro |
| Mar 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sanara MedTech | 101.88M |
| Pro-Dex | 72.10M |
| Stereotaxis | 30.08M |
| Precision Optics Corporation | 24.42M |
| Nephros | 17.93M |
| Ekso Bionics Holdings | 12.80M |
| Nyxoah | 6.62M |
| Femasys | 2.06M |
ZTEK News
- 3 hours ago - Zentek Provides PDAC 2026 Update - Government and First Nations Engagement - Accesswire
- 5 days ago - Zentek Announces Pilot Evaluation Program with Quality Filters Inc. - Accesswire
- 11 days ago - Zentek Outlines Government Engagement Strategy and Announces Plans to Advance Albany Graphite Toward New Preliminary Economic Assessment - Accesswire
- 12 days ago - Zentek Ltd. Granted 180-Day Extension to Regain Compliance with Nasdaq's Minimum Bid Price Requirement - Accesswire
- 20 days ago - Zentek Provides Strategic and Regulatory Update - Accesswire
- 5 weeks ago - Zentek Issues Shareholder Letter Outlining Strategic Reset and Focused Growth Plan - Newsfile Corp
- 2 months ago - Zentek's Albany Graphite Has Demonstrated Nuclear Grade Performance in Independent Testing, Opening Pathways Into a Range of High-Return Commercial Markets - Accesswire
- 2 months ago - Zentek Subsidiary Albany Graphite Corp. Achieves Near-Theoretical Anode Performance in Battery Suitability Independent Testing - Accesswire